-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 CUV70r4qMEUzjLHiETezK/Beyd7v2TwL2C9WklsTMHjCOGQ1ShDFEbX4ak60q8mK
 iLLJKwdEKAF1DhJArcEyMw==

<SEC-DOCUMENT>0001085596-09-000002.txt : 20091203
<SEC-HEADER>0001085596-09-000002.hdr.sgml : 20091203
<ACCEPTANCE-DATETIME>20091202182744
ACCESSION NUMBER:		0001085596-09-000002
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		Rule 506
FILED AS OF DATE:		20091203
DATE AS OF CHANGE:		20091202
EFFECTIVENESS DATE:		20091203

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AngioGenex, Inc.
		CENTRAL INDEX KEY:			0001085596
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				860945116
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-136569
		FILM NUMBER:		091218584

	BUSINESS ADDRESS:	
		STREET 1:		425 MADISON AVENUE, SUITE 902
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		212-874-6608

	MAIL ADDRESS:	
		STREET 1:		425 MADISON AVENUE, SUITE 902
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ECLIC INC/NV
		DATE OF NAME CHANGE:	19990430
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0603</schemaVersion>

    <submissionType>D</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001085596</cik>
        <entityName>AngioGenex, Inc.</entityName>
        <issuerAddress>
            <street1>425 MADISON AVENUE, SUITE 902</street1>
            <city>NEW YORK</city>
            <stateOrCountry>NY</stateOrCountry>
            <zipCode>10017</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>212-874-6608</issuerPhoneNumber>
        <jurisdictionOfInc>NEVADA</jurisdictionOfInc>
        <edgarPreviousNameList>
            <previousName>ECLIC INC/NV</previousName>
        </edgarPreviousNameList>
        <entityType>Corporation</entityType>
        <yearOfInc>
            <overFiveYears>true</overFiveYears>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>William</firstName>
                <lastName>Garland</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>425 Madison Avenue, Ste. 902</street1>
                <city>New York</city>
                <stateOrCountry>NY</stateOrCountry>
                <zipCode>10017</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification>CEO and COO</relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Martin</firstName>
                <lastName>Murray</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>425 Madison Avenue, Ste. 902</street1>
                <city>New York</city>
                <stateOrCountry>NY</stateOrCountry>
                <zipCode>10017</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification>CFO, Secretary and Treasurer</relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Michael</firstName>
                <lastName>Strage</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>425 Madison Avenue, Ste. 902</street1>
                <city>New York</city>
                <stateOrCountry>NY</stateOrCountry>
                <zipCode>10017</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Richard</firstName>
                <lastName>Salvador</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>425 Madison Avenue, Ste. 902</street1>
                <city>New York</city>
                <stateOrCountry>NY</stateOrCountry>
                <zipCode>10017</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Pharmaceuticals</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>No Revenues</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>false</isAmendment>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2009-11-16</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>false</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isEquityType>true</isEquityType>
            <isOtherType>true</isOtherType>
            <descriptionOfOtherType>Units consisting of one share of common stock, plus one warrant to purchase Common Stock.</descriptionOfOtherType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>false</isBusinessCombinationTransaction>
            <clarificationOfResponse></clarificationOfResponse>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>25000</minimumInvestmentAccepted>
        <salesCompensationList>
            <recipient>
                <recipientName>Choice Investments, Inc.</recipientName>
                <recipientCRDNumber>17665</recipientCRDNumber>
                <associatedBDName>John D. Trenholm</associatedBDName>
                <associatedBDCRDNumber>1053437</associatedBDCRDNumber>
                <recipientAddress>
                    <street1>4800 Bee Cave Road</street1>
                    <city>Austin</city>
                    <stateOrCountry>TX</stateOrCountry>
                    <zipCode>78746</zipCode>
                </recipientAddress>
                <statesOfSolicitationList>
                    <state>AL</state>
                    <state>AZ</state>
                    <state>CA</state>
                    <state>CO</state>
                    <state>FL</state>
                    <state>GA</state>
                    <state>ID</state>
                    <state>NC</state>
                    <state>OH</state>
                    <state>OK</state>
                    <state>TX</state>
                </statesOfSolicitationList>
            </recipient>
            <recipient>
                <recipientName>Choice Investments, Inc.</recipientName>
                <recipientCRDNumber>17665</recipientCRDNumber>
                <associatedBDName>William H. Watson, III</associatedBDName>
                <associatedBDCRDNumber>1016938</associatedBDCRDNumber>
                <recipientAddress>
                    <street1>4800 Bee Cave Road</street1>
                    <city>Austin</city>
                    <stateOrCountry>TX</stateOrCountry>
                    <zipCode>78746</zipCode>
                </recipientAddress>
                <statesOfSolicitationList>
                    <state>CA</state>
                    <state>FL</state>
                    <state>IA</state>
                    <state>LA</state>
                    <state>ME</state>
                    <state>MN</state>
                    <state>NY</state>
                    <state>TX</state>
                    <state>WA</state>
                </statesOfSolicitationList>
            </recipient>
        </salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>500000</totalOfferingAmount>
            <totalAmountSold>25000</totalAmountSold>
            <totalRemaining>475000</totalRemaining>
            <clarificationOfResponse></clarificationOfResponse>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>false</hasNonAccreditedInvestors>
            <totalNumberAlreadyInvested>1</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>80000</dollarAmount>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse>(i) 13% of gross proceeds; (ii) $10,000 retainer; (iii) $5,000 promissory note; (iv) warrants to purchase common stock; and (v) 1,000,000 shares of common stock</clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>0</dollarAmount>
            </grossProceedsUsed>
            <clarificationOfResponse></clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>AngioGenex, Inc.</issuerName>
                <signatureName>William Garland</signatureName>
                <nameOfSigner>William Garland</nameOfSigner>
                <signatureTitle>Chief Executive Officer</signatureTitle>
                <signatureDate>2009-12-02</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----